Growth Metrics

Evolent Health (EVH) Cash from Investing Activities (2016 - 2026)

Evolent Health has reported Cash from Investing Activities over the past 11 years, most recently at $82.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 512.21% year-over-year to $82.2 million; the TTM value through Dec 2025 reached -$233000.0, up 99.63%, while the annual FY2025 figure was -$233000.0, 99.63% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $82.2 million at Evolent Health, up from -$8.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $82.2 million in Q4 2025 and troughed at -$395.0 million in Q1 2023.
  • A 5-year average of -$37.7 million and a median of -$9.2 million in 2024 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 525.2% in 2021 and later tumbled 14081.81% in 2022.
  • Year by year, Cash from Investing Activities stood at -$54.4 million in 2021, then skyrocketed by 91.8% to -$4.5 million in 2022, then tumbled by 35.82% to -$6.1 million in 2023, then tumbled by 229.31% to -$19.9 million in 2024, then soared by 512.21% to $82.2 million in 2025.
  • Business Quant data shows Cash from Investing Activities for EVH at $82.2 million in Q4 2025, -$8.8 million in Q3 2025, and -$60.5 million in Q2 2025.